300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Nepal
Togo
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Romania
Pakistan
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Avançsa, VC Fund

Avançsa

VC Fund

Avançsa is a VC fund focused on Software and Manufacturing. Private equity arm of Generalitat de Catalunya .

Total investments:
21
Last investment:
Lead investor:
71%

Last updated:

Industries Avançsa invests in

SoftwareManufacturingMedical DeviceInformation TechnologyClean Energy

Stages Avançsa invests in

Debt FinancingVenture - Series UnknownSeedSeries ASeries B

Countries Avançsa invests in

Spain

Round sizes

Debt Financing $541k–$2.4MVenture - Series Unknown $2.1M–$8.4M

Round size

Debt Financing
$541k–$2.4M
Venture - Series Unknown
$2.1M–$8.4M

Investment Focus

Industry

  • Software 4 (19%)
  • Manufacturing 3 (14%)
  • Medical Device 3 (14%)
  • Information Technology 3 (14%)
  • Clean Energy 2 (10%)
See all 51 industries →

Stage

  • Debt Financing 12 (57%)
  • Venture - Series Unknown 4 (19%)
  • Seed 1 (5%)
  • Series A 1 (5%)
  • Series B 1 (5%)
See all 7 stages →

Investments

CompanyDescriptionRoundLinks
Floox llega para diseñar, desarrollar y fabricar puntos de carga rápida en corriente continua para vehículos eléctricos. Somos un equipo de más 120 personas trabajando para revolucionar la movilidad eléctrica y así crear un mundo más efectivo, fácil y sostenible. $2.3M / Venture - Series Unknown / Jun 17, 2026
INGALSA specializing in hot-dip galvanizing of steel parts and fasteners. $813.7K / Debt Financing / Nov 14, 2025
NEOS Surgery is a technology-based company dedicated to the creation of medical devices for neurosurgery. The company focuses on the R&D, design, production, and commercialization of innovative implants in the fields of cranial and spinal surgery. Our products aim at occupying the niches of the current market by responding to the needs of bothpatients and neurosurgeons.NEOS is a certified producer of medical devices and implements the complete ISO 9001: 2008 and ISO 13485: 2003 / AC: 2007 quality systems.NEOS Surgery’s mission is to capture the demands of the Neurosurgery market in order to develop, manufacture, certify and commercialize new devices, which create company value and foster a high added-value industry. $582.3K / Debt Financing / Oct 15, 2025
X1 Wind is a disruptive floating platform developing a floating wind platform for deep waters. The platform has redesigned floating wind platforms to reduce costs by 50percent and weight 80percent while expanding the operation depth range in comparison to other floating solutions. It has less active systems than current designs and can be fullyassembled at the port and then installed using a small tug boat.X1 Wind helps to achieve a radical weight reduction in floating wind structures to current semi-submersible and spar systems. It was founded in 2017 and is based in Barcelona, Spain. $641.6K / Convertible Note / Jul 14, 2025
NearbyComputing commercializes NearbyOne, an Edge IT fabrics orchestration platform that seamlessly manages the lifecycle of infrastructure, the VNFs and the applications, controlling their deployment and associated resources. NearbyOne addresses all these orchestration issues in a holistic and intertwined way. Applications and VNFs provided bythird party ISVs are onboarded to create a rich ecosystem of pre-integrated services, that get deployed in one-click. Service assurance and KPI monitoring are natively integrated into the platform to automatically control service SLAs. Infratructure, Network, Apps and KPIs are managed from a single pane of glass, and smart placement and configuration policies dynamically adjust service levels. $559.3K / Debt Financing / May 13, 2025
INBRAIN Neuroelectronics is pioneering real time precision neurology with the world’s first graphene-based brain-computer interface (BCI) therapeutics platform. Our technology combines precise BCI decoding with micrometric modulation to deliver adaptive, personalized treatments for conditions such as Parkinson’s disease, epilepsy, and strokerehabilitation. By providing continuous real-time monitoring and autonomous therapy adjustments, our AI-driven platform maximizes therapeutic outcomes while minimizing side effects. Through strategic collaborations, including with Merck KGAa and our subsidiary INNERVIA Bioelectronics, we are extending our innovative solutions to peripheral nerve and systemic disease applications, unlocking the potential of neurotechnology and bioelectronics. For more information, visit www.inbrain-neuroelectronics.com and follow us on LinkedIn. $49.8M / Series B / Oct 29, 2024
Qilimanjaro is a quantum computing company based in Barcelona, making quantum useful today. Founded in 2019, we develop full-stack quantum computers based on fluxonium analog qubits, a novel architecture that bypasses the need for error correction, enabling faster, more scalable solutions. Our approach is application-first: analog quantum computingoffers near-term advantages and optimality for highly relevant problems, especially in simulation, optimization, and AI, where digital QPUs fall short. We follow a dual strategy to democratize access to quantum computing:• Via our Quantum-as-a-Service (QaaS) platform, users can remotely access our hybrid quantum data centers, combining analog and digital QPUs with classical HPC. • For research institutions and HPC centers, we provide on-premise quantum deployments, offering flexibility, control, and co-design.By aligning quantum hardware with real-world needs, Qilimanjaro is building a future where quantum computing is practical, scalable, and ready to deliver value - not in decades, but now. $1.6M / Debt Financing / Jul 18, 2024
Ocean Ecostructures is the developer of a biodiversity regeneration program that will assist businesses and governments in transitioning to a blue economy. $540.6K / Debt Financing / Jun 12, 2024
visual+cognitive enhancement $4.3M / Series A / Feb 19, 2024
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations. $761.5K / Debt Financing / Jan 16, 2024
See all 21 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Nepal
Togo
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Romania
Pakistan
Oman
Puerto Rico
Poland
Guernsey
Cameroon
Sudan
Andorra
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Avançsa invest in?

Avançsa invests primarily in Software, Manufacturing and Medical Device startups, most often at Debt Financing and Venture - Series Unknown stage. Most of the 21 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Avançsa's check size?

Avançsa typically joins rounds of $541k–$2.4M at Debt Financing and $2.1M–$8.4M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Avançsa participates in.

When did Avançsa last invest?

The most recent investment recorded for Avançsa closed in Jun 2026. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Avançsa Avançsa Find emails